French drugmaker Sanofi announced on April 10 a plan to lower its insulin prices to $99 per month for some U.S. patients, beginning in June. The announcement came amid a series of congressional hearings about drug costs and was met with questions about why this move and other recent cost-cutting measures took so long.

Dietary risk factors—such as consuming too much sodium or not enough whole grains and fruits—were responsible for 11 million deaths globally in 2017, according to a new analysis in The Lancet.

The actual cost of a heart attack or stroke to society is about double the direct medical costs when lost productivity for patients and caregivers is considered, according to a study published April 6 in the European Journal of Preventive Cardiology.

Counties in states that expanded Medicaid coverage under the Affordable Care Act (ACA) had fewer deaths from cardiovascular disease than those in states that didn’t expand Medicaid, according to an abstract presented April 5 at the American Heart Association’s Quality of Care and Outcomes Research scientific sessions.

Diabetics enrolled in certain drug benefits plans through Cigna and Express Scripts could see their out-of-pocket costs for insulin capped at $25 per month, according to an April 3 announcement. But one diabetes advocate called the move "a stopgap at best" and said it doesn't address the larger issue of sky-high list prices.

The federal mandate that went into effect Jan. 1 requiring hospitals to post prices of their services online isn’t doing much good, according to the authors of an opinion piece published in the Annals of Internal Medicine.

In a first step to develop a set of AI-specific rules and regulations, the FDA released a discussion paper April 3 detailing how it plans to vet and approve AI medical devices without compromising quality or patient safety.

CMS has proposed an update to its national coverage policy for transcatheter aortic valve replacement (TAVR), which would require hospitals to perform 50 aortic valve replacements each year to maintain a TAVR program—including at least 20 TAVRs.